Prøve GULL - Gratis
SEVEN HEAD AND NECK CANCER MYTHS DOCTORS MUST EDUCATE PATIENTS ABOUT
Healthcare Radius
|September 2024
Debunk head and neck cancer myths. Separate facts from fiction to promote early detection. Learn what you must inform your patients about.

Head and neck cancers are a major global health concern, affecting thousands of people each year. In India, the burden of cancer is significant, with approximately 14 lakh (1.4 million) new cancer cases and over nine-lakh (9,00,000) deaths reported in 2022.
Despite the widespread prevalence, there are various misunderstandings about these malignancies, which can delay detection and affect treatment outcomes. Here, we address and clarify seven prevalent myths that clinicians should actively educate patients about:
Myth 1: A persistent cough or throat sensation is a sure sign of cancer
Fact: While a chronic cough or the sensation of something stuck in the throat (glothey are not the only causes. Additional factors include:
• Poor dental hygiene, including gum disease, can raise the risk of oral cancer.
• Human Papillomavirus, specifically HPV16, has been related to head and neck malignancies, notably oropharyngeal cancer (cancer of the back of the throat).
• Epstein-Barr virus (EBV) infection is linked to some head and neck cancers, specifically nasopharyngeal cancer.
• Occupational exposure to substances such as asbestos and wood dust can raise the risk of head and neck cancer.
Men are more likely than women to develop these malignancies, and the risk increases with age, particularly after 50. Understanding these diverse risk factors empowers bus sensation) can be alarming, they are not clear signs of head and neck cancer. More serious symptoms include:
• Sore throat, particularly on one side (unilateral)
• Persistent voice changes, such as hoarseness
• Difficulty swallowing (dysphagia or odynophagia) While these symptoms require medical treatment, they might be caused by a variety of diseases other than cancer. Early consultation with a doctor is critical for a correct diagnosis and treatment.
Denne historien er fra September 2024-utgaven av Healthcare Radius.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Healthcare Radius

Healthcare Radius
ASTER DM HEALTHCARE EXPANDS BENGALURU FOOTPRINT WITH RS 580 CRORE HOSPITAL
Aster DM Healthcare has announced an Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.
1 min
September 2025

Healthcare Radius
COULD DONALD TRUMP'S TRADE MOVES HIT INDIA'S PHARMA EXPORTS NEXT?
If tariffs hit, medicines could cost more in the U.S., and India's drug industry could take a hit. For now, it's all talk, but India's pushing for trade deals and new markets to stay strong.
3 mins
September 2025

Healthcare Radius
HCG TREATS 33-YR-OLD PATIENT WITH SCARLESS CANCER SURGERY
HCG Manavata Cancer Centre (HCGMCC) successfully performed a scarless intraoral surgery on a 33-year-old male diagnosed with buccal mucosa (cheek) cancer.
1 min
September 2025

Healthcare Radius
CELCIUS LOGISTICS LAUNCHES PHARMA COLD CHAIN ARM WITH RS 50CR INVESTMENT
Celcius Logistics has announced the launch of Celcius+, a specialised logistics arm dedicated exclusively to the seamless management of the pharmaceutical supply chain.
1 min
September 2025

Healthcare Radius
PFIZER LAUNCHES 20-VALENT PNEUMONIA VACCINE FOR ADULTS IN INDIA
Pfizer announced the launch of its nextgeneration 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITAL APPOINTS DR. SURENDER DABAS TO LEAD ROBOTIC CANCER CARE IN DELHI
Manipal Hospital welcomes one of India's most renowned and celebrated robotic onco-surgeons, Dr. Surender Kumar Dabas, as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster.
1 min
September 2025

Healthcare Radius
ZYDUS RECEIVES USFDA APPROVAL FOR CONSTIPATION DRUG PRUCALOPRIDE
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Prucalopride Tablets, 1 mg and 2 mg (USRLD: Motegrity Ⓡ Tablets, 1mg and 2 mg).
1 min
September 2025

Healthcare Radius
SSI PERFORMS WORLD'S FIRST CARDIAC TELESURGERY ACROSS 10,000 KM
SS Innovations International, Inc. has achieved a historic milestone at the Annual Conference of the Society of Robotic Surgery (SRS) in Strasbourg, France, with the successful completion of two complex transcontinental robotic telesurgeries using the indigenously developed SSI Mantra Surgical Robotic System.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITALS SIGNS MOU WITH MAHA GOVT TO INVEST RS 700CR IN NEW NAGPUR HOSPITAL
Manipal Hospitals has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to build a state-of-the-art 350-bed multi-speciality Hospital at Nagpur.
1 min
September 2025

Healthcare Radius
INSIDE INDIA'S AMR CHALLENGE: FIXING AWARENESS, DIAGNOSTICS AND HOSPITAL POLICY GAPS
Dr. Narendra Saini of the IMA unpacks India's escalating AMR crisis, highlighting solutions to bridge awareness, diagnostics and policy gaps in the fight against a looming public health threat.
9 mins
September 2025
Listen
Translate
Change font size